COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE
1 Assignment
0 Petitions
Accused Products
Abstract
Compositions and methods for the therapy and diagnosis of Inflammatory Bowel Disease (IBD), including Crohn'"'"'s Disease and Ulcerative Colitis, are disclosed. Illustrative compositions comprise one or more bacterial polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of IBD.
-
Citations
97 Claims
-
1-72. -72. (canceled)
- 73. An isolated polypeptide comprising an amino acid sequence having at least 90% identity to the sequence set forth in SEQ ID NO:
-
81. An isolated polypeptide fragment comprising at least about 25, 50, 100 or more contiguous amino acids of the sequence of SEQ ID NO:
- 79, wherein the polypeptide fragment is immunologically reactive with an antibody that binds to the full-length polypeptide of SEQ ID NO;
79. - View Dependent Claims (82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92)
- 79, wherein the polypeptide fragment is immunologically reactive with an antibody that binds to the full-length polypeptide of SEQ ID NO;
-
93. An isolated polynucleotide comprising a sequence selected from the group consisting of:
-
(a) the sequence provided in SEQ ID NO 75; (b) the complement of the sequence provided in SEQ ID NO 75; (c) sequences having at least 75% identity to the sequence of SEQ ID NO 75; and (d) sequences having at least 90% identity to the sequence of SEQ ID NO 75. - View Dependent Claims (95, 97)
-
Specification